Fagron

Today, our CEO and CFO presented our Q3 results, showcasing our outstanding performance with a 12.1% increase in reported revenue. We also announced three acquisitions in Germany, Brazil, and North America. “Q3 has been another strong period for Fagron, highlighting the strength of our business model and the consistent execution of our strategy. Our focus on operational excellence and targeted growth investments continues to deliver positive results across all regions,” stated Rafael Padilla, CEO. If you missed the live presentation, you can watch the recording here: https://lnkd.in/eYTq6tPX

A True Fagron Star ⭐ Dani, who has been with our company since 2012, just received a well-deserved Certificate of Appreciation. At 83 years old, Dani is not only a dedicated machine operator in the production department but also the oldest employee in our global group—a testament to his incredible energy and passion for his work! He is known for his positive outlook and his belief that staying healthy means staying active! He works half a day at Fagron, then heads home to have lunch with his wife. Every morning, when asked how he's doing, he cheerfully replies, "If I'm here, then I'm doing great!" Dani’s constant smile brightens the workplace. His optimism and dedication inspire us all, reminding us of the power of hard work and positivity. We’re lucky to have you on our team, Dani! ❤

📰 New Publication on Cleoderm™ and its Role in Dermatological Treatments We are excited to announce that our latest research on #Cleoderm™ has been published in the International Journal of Pharmaceutical Compounding. This study focuses on the stability and compatibility of active pharmaceutical ingredients (APIs) in #Cleoderm™, validating its role in enhancing topical dermatological treatments. We are committed to advancing dermatological care tailored to meet each individual's unique needs. You can read the complete study on Fagron Library https://lnkd.in/emk3CjnA and learn more about Cleoderm™ here https://lnkd.in/exBpXFhM #Dermatology #Cleoderm #ScientificResearch #Innovation #PharmaceuticalCompounding

Child Health Day is celebrated on the first Monday of October. This day reminds us of the importance of ensuring every child has access to the best possible care. At the heart of personalized medicine is the commitment to making healthcare accessible to all patients. That's why we created SyrSpend® SF — a tailored approach for pediatric and neonatal care, that provides pharmaceutical stability, dosage consistency, and most importantly, patient comfort. We’re making sure even the littlest patients get safe, effective, and personalized healthcare solutions. You can read more at: https://lnkd.in/esc7Cnt5 #ChildHealthDay #PediatricCare #SyrSpendSF|

To Our Valued Customers, We are keenly aware of the devastation caused by Hurricane Helene and associated storms. Helene has been the deadliest mainland US hurricane since Hurricane Katrina. We recognize the severity these events are having on the healthcare supply chain and your ability to serve patients. As part of a global leader in pharmaceutical compounding, Fagron is leveraging our vast network of supply chain experts who are working around the clock to secure and safeguard product supply. While we continue to assess the full extent of the disruption, we remain committed to collaborating with our customers and global suppliers to address the needs of patients. We are working closely with our customers and have established an allocation process for several of our products. This process is intended to help maintain continuity of supply across our customer base. We will keep you informed as the situation evolves. If you or your organization have been directly affected by these events, please know that our thoughts are with you during this difficult time. Please feel free to reach out to your Fagron Sterile Services representative with any questions or additional needs. Thank you for your continued support, Ray Dixon SVP, Commercial Operation

📅 Save the date! From 17 to 20 October 2024, the Congress of the European Academy of Paediatric Societies (EAPS) will take place in Vienna – and Fagron will be there! Don't miss out! Discover the exciting program and visit us at booth 27. More details are below on the Fagron GmbH post.

Fagron Q3 2024 Results Announcement We are pleased to invite you to join us for the presentation of Fagron's Q3 2024 results on October 10th at 9.30 am CET. Our CEO, Rafael Padilla, and CFO, Karin De Jong, will provide an overview of the company's performance and future developments. To watch the live presentation, you can register at https://lnkd.in/eYTq6tPX

Today, Fagron is proud to have a global team of over 4,000 employees working across more than 70 facilities in 30 different countries. This worldwide presence allows us to continually innovate and serve our customers with excellence. At our Annual Leadership Meeting, we are excited to recognize an outstanding leader who has made significant contributions to our success. We are thrilled to announce that Ray Dixon, SVP of Commercial Operations for Fagron Sterile Services US (FSS), is the recipient of the 2024 Fagron Business Leader of the Year award! 🏆 "I am truly honored to receive this award. It reflects not just my efforts, but the dedication and passion of the entire FSS team. Thank you for this recognition — I'm excited for what we will accomplish together in the future," said Ray. Join us in congratulating Ray for this outstanding achievement and continued dedication to excellence! 👏 #Fagron #Leadership #BusinessLeader2024 #503B #Innovation

Fagron is excited to announce the publication of a new study on TrichoSol™, our widely-used vehicle for hair solutions in the treatment of alopecia. This research explores its physical, chemical, and microbiological stability with various active ingredients. To access the full study, visit the Fagron Library: https://lnkd.in/emk3CjnA

We are very proud to have been a part of the USP Annual Compounding Implementation Workshop, organized by the United States Pharmacopeia. Being among the top industry experts in our field was a pleasure and an honor!